ResearcherShanxi Medical UniversityNo recent work listed

Xifeng Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7540-2379; OpenAlex author ID A5113219259. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2. Co-author DOI 10.3892/ol.2021.12887 ↗
The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation. Co-author DOI 10.3892/ol.2019.11121 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Haoliang Zhao · 2 shared papers, 2020–2021 · strength 0.27
- Paper MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibrobl… DOI 10.3892/ol.2021.12887 ↗
- Paper The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation. DOI 10.3892/ol.2019.11121 ↗
Xidong Chen · 1 shared paper, 2020 · strength 0.13
- Paper The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation. DOI 10.3892/ol.2019.11121 ↗
Jian Li · 1 shared paper, 2020 · strength 0.13
- Paper The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation. DOI 10.3892/ol.2019.11121 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.